Bevacizumab Diminishes Inflammation in an Acute Endotoxin-Induced Uveitis Model-Reference-Cited by-同舟云学术

Bevacizumab Diminishes Inflammation in an Acute Endotoxin-Induced Uveitis Model

Published:2018-06-19 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Mérida Salvador,Sancho-Tello María,Almansa Inmaculada,Desco Carmen,Peris Cristina,Moreno Mari-Luz,Villar Vincent M.,Navea Amparo,Bosch-Morell Francisco

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference82 articles.

1. Proteomic analyses of the vitreous humour.;Angi;Mediators Inflamm.,2012

2. Comparative evaluation of apoptotic activity in photoreceptor cells after intravitreal injection of bevacizumab and pegaptanib sodium in rabbits.;Avci;Invest. Ophthalmol. Vis. Sci.,2009

3. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines.;Banchereau;Nat. Immunol.,2012

4. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.;Bock;Invest. Ophthalmol. Vis. Sci.,2007

5. 4-Hydroxynonenal inhibits glutathione peroxidase: protection by glutathione.;Bosch-Morell;Free Radic. Biol. Med.,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids;Biomedicines;2023-12-30

2. Anatomical and Functional Outcomes with Prompt versus Delayed Initiation of Anti-VEGF in Exudative Age-Related Macular Degeneration;Journal of Clinical Medicine;2023-12-25

3. Metronomic Temozolomide (mTMZ) and Bevacizumab—The Safe and Effective Frontier for Treating Metastatic Neuroendocrine Tumors (NETs): A Single-Center Experience;Cancers;2023-12-01

4. Proteome Analysis of Bevacizumab Intervention in Experimental Central Retinal Vein Occlusion;Journal of Personalized Medicine;2023-11-07

5. Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate;Biomedicines;2023-05-27